Stem Cell-Derived Layered Synthetic Leather for Structural Accuracy

The patent divides the synthetic leather production into distinct segmented stages: forming artificial dermal layers with fibroblasts, creating artificial epidermal layers with keratinocytes, combining them with basement membrane substitutes, and performing sequential post-processing operations. This segmentation allows each layer to be optimized independently for structural accuracy while maintaining manageable production complexity.

The patent applies preliminary action by pre-differentiating stem cells into specific cell types (fibroblasts and keratinocytes) before layer formation, and by pre-forming individual layers with their specific cellular compositions and extracellular matrix components. This preliminary preparation ensures that when layers are combined, they immediately achieve the desired structural accuracy resembling natural leather, reducing the need for complex post-assembly adjustments.

The patent applies local quality by assigning specific cell types to specific layers: fibroblasts in the dermal layer for structural integrity and collagen production, keratinocytes in the epidermal layer for protective function and appearance, and melanocytes for pigmentation. Each layer is engineered with locally appropriate cellular and extracellular components that replicate the functional properties of natural leather at that specific location, thereby improving durability and appearance without requiring complex overall production systems.

The patent creates composite materials by combining multiple cell types (fibroblasts, keratinocytes, melanocytes) with their respective extracellular matrix components (collagen, elastin, proteoglycans) and basement membrane substitutes in a layered architecture. This composite approach allows each component to contribute its specific functional properties, achieving high durability and natural appearance through the synergistic interaction of simplified individual elements rather than requiring complex monolithic structures.

The patent implements continuity of useful action by establishing continuous culture conditions for cell proliferation and extracellular matrix deposition throughout the layer formation process. The artificial dermal and epidermal layers are cultured in vitro under optimized conditions that continuously promote cellular differentiation, matrix production, and layer maturation. This continuous action allows the layers to naturally develop their desired thickness and texture over time without requiring repeated interruption for processing, thereby reducing overall production time while achieving high manufacturing precision.

The patent applies self-service by enabling the cultured cell layers to autonomously produce their own extracellular matrix components (collagen, elastin, proteoglycans) and undergo spontaneous differentiation into mature tissue structures with natural leather-like thickness and texture. The fibroblasts self-organize to produce dermal matrix, keratinocytes self-differentiate to form epidermal layers with appropriate stratification, and the combined structure self-assembles into a cohesive tissue equivalent. This self-organizing capability eliminates the need for complex external shaping and texturing operations, reducing production time while achieving accurate texture replication.